Sign inGet started

ALTOMARI ALFRED

Insider CIK 1285644 · INSM Director · AGRX Chief Executive Oficer, Director · REPH Director · BXRX Director · DUSA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AGRX AGILE THERAPEUTICS INC D To issuer2024-08-262024-08-2628,125$1.52 $42.8K19,624SEC↗
AGRX AGILE THERAPEUTICS INC D To issuer2024-08-262024-08-2619,624$1.52 $29.8K0SEC↗
INSM INSMED Inc A Award2024-05-132024-05-1513,162— $069,495SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2023-06-282023-06-3012,500— $012,500SEC↗
AGRX AGILE THERAPEUTICS INC A Award2023-06-282023-06-308,963— $047,749SEC↗
AGRX AGILE THERAPEUTICS INC A Award2023-06-282023-06-3037,500— $038,786SEC↗
INSM INSMED Inc A Award2023-05-112023-05-1513,192— $056,333SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2022-11-092022-11-1430,000— $030,000SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2022-08-262022-08-2950,000$0.45 $22.5K64,343SEC↗
INSM INSMED Inc A Award2022-05-112022-05-1314,645— $043,141SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2022-01-192022-01-20675,000— $0675,000SEC↗
AGRX AGILE THERAPEUTICS INC P Buy deriv2021-10-132021-10-1429,412— $029,412SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2021-10-132021-10-1458,824— $0573,734SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2021-07-292021-07-2926,200$1.26 $33.0K514,910SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2021-05-182021-05-1920,000$1.61 $32.2K488,710SEC↗
INSM INSMED Inc A Award2021-05-122021-05-147,558— $028,496SEC↗
BXRX Baudax Bio, Inc. A Award deriv2021-04-072021-04-0883,333— $083,333SEC↗
BXRX Baudax Bio, Inc. A Award2021-04-072021-04-0856,452— $0117,785SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2021-03-232021-03-2312,500$2.00 $25.0K468,710SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2021-01-272021-01-28692,641— $0692,641SEC↗
INSM INSMED Inc S Sale2020-12-072020-12-0920,000$39.57 $791.4K20,938SEC↗
BXRX Baudax Bio, Inc. P Buy2020-11-232020-11-245,000$1.06 $5.3K61,333SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2020-08-202020-08-2094,599— $00SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2020-08-202020-08-2094,599$1.76 $166.5K456,210SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2020-06-222020-06-2350,000— $094,599SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2020-06-222020-06-2350,000$1.76 $88.0K361,611SEC↗
INSM INSMED Inc A Award2020-05-122020-05-148,097— $040,938SEC↗
BXRX Baudax Bio, Inc. A Award deriv2020-05-062020-05-0834,574— $034,574SEC↗
BXRX Baudax Bio, Inc. A Award2020-05-062020-05-0822,951— $056,333SEC↗
BXRX Baudax Bio, Inc. P Buy2020-03-262020-03-275,000$2.34 $11.7K33,382SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2020-02-272020-02-2716,541— $00SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2020-02-272020-02-2716,541$0.71 $11.7K301,611SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2020-02-272020-02-2710,000$2.71 $27.1K311,611SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2020-01-222020-01-24833,333— $0833,333SEC↗
AGRX AGILE THERAPEUTICS INC A Award2020-01-222020-01-2426,502— $0285,070SEC↗
BXRX Baudax Bio, Inc. A Award2019-12-052019-12-0920,000— $028,382SEC↗
REPH Recro Pharma, Inc. A Award2019-12-052019-12-0915,284— $044,196SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2019-06-102019-06-1120,000$1.27 $25.4K258,568SEC↗
INSM INSMED Inc A Award2019-05-152019-05-166,899— $032,841SEC↗
REPH Recro Pharma, Inc. A Award deriv2019-05-092019-05-1010,888— $010,888SEC↗
REPH Recro Pharma, Inc. A Award2019-05-092019-05-107,955— $028,912SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2019-03-252019-04-0125,000$1.54 $38.5K238,568SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2019-03-252019-03-2625,000$1.54 $38.5K238,568SEC↗
INSM INSMED Inc S Sale2019-02-262019-02-275,500$30.00 $165.0K25,942SEC↗
INSM INSMED Inc S Sale2019-02-152019-02-205,500$27.50 $151.3K31,442SEC↗
INSM INSMED Inc S Sale2019-02-052019-02-075,500$25.00 $137.5K36,942SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2019-01-292019-01-31154,400— $0154,400SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2019-01-292019-01-31540,900— $0540,900SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2019-01-242019-01-2835,314— $00SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2019-01-242019-01-2835,314— $0213,568SEC↗
INSM INSMED Inc S Sale2019-01-102019-01-145,500$22.50 $123.8K42,442SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2018-06-202018-06-21150,000— $0150,000SEC↗
INSM INSMED Inc A Award2018-05-152018-05-176,066— $047,942SEC↗
REPH Recro Pharma, Inc. M Exercise deriv2018-05-122018-05-1413,274— $00SEC↗
REPH Recro Pharma, Inc. M Exercise2018-05-122018-05-1413,274— $020,957SEC↗
REPH Recro Pharma, Inc. A Award deriv2018-05-042018-05-085,742— $05,742SEC↗
REPH Recro Pharma, Inc. A Award deriv2018-05-042018-05-108,965— $08,965SEC↗
REPH Recro Pharma, Inc. A Award2018-05-042018-05-086,183— $07,683SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2018-02-082018-02-0916,667— $035,314SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2018-02-082018-02-0916,667— $0178,254SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2018-01-242018-01-26256,000— $0256,000SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2018-01-242018-01-2635,314— $051,981SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2017-08-252017-08-2810,000$3.34 $33.4K161,587SEC↗
INSM INSMED Inc A Award2017-05-172017-05-196,702— $041,876SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-05-122017-05-1613,274— $013,274SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2017-05-112017-05-1210,000$3.51 $35.1K151,587SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2017-04-112017-04-1230,000— $0144,599SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2017-04-112017-04-1230,000$1.76 $52.8K141,587SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2017-02-082017-02-1016,667— $016,667SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2017-02-082017-02-1016,667— $0111,587SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2017-01-252017-01-27240,000— $0240,000SEC↗
REPH Recro Pharma, Inc. P Buy2016-12-152016-12-161,500$6.55 $9.8K1,500SEC↗
INSM INSMED Inc A Award2016-05-192016-05-2312,742— $035,174SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2016-02-082016-02-10100,000— $0100,000SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2016-02-082016-02-1016,666— $033,334SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2016-02-082016-02-1050,000— $050,000SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2016-02-082016-02-1016,666— $094,920SEC↗
REPH Recro Pharma, Inc. A Award deriv2015-12-162015-12-1810,000— $010,000SEC↗
AGRX AGILE THERAPEUTICS INC P Buy2015-06-022015-06-032,500$8.73 $21.8K78,254SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2015-03-112015-03-1117,500— $0174,599SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2015-03-112015-03-1117,500$1.76 $30.8K75,754SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2015-02-192015-02-2390,000— $090,000SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2015-02-192015-02-2390,000— $090,000SEC↗
INSM INSMED Inc A Award2015-01-082015-01-096,222— $022,432SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise deriv2014-12-182014-12-2230,000— $0192,099SEC↗
AGRX AGILE THERAPEUTICS INC M Exercise2014-12-182014-12-2230,000$1.76 $52.8K58,254SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172014-12-1922,000— $022,000SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2014-06-242014-06-2672,500— $072,500SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-03-122014-03-1320,000— $020,000SEC↗
INSM INSMED INC M Exercise deriv2014-01-112014-01-148,955— $00SEC↗
INSM INSMED INC M Exercise2014-01-112014-01-148,955— $016,210SEC↗
INSM INSMED INC A Award2014-01-102014-01-142,928— $07,255SEC↗
INSM INSMED INC M Exercise deriv2013-08-022013-10-044,327— $00SEC↗
INSM INSMED INC M Exercise2013-08-022013-10-044,327— $04,327SEC↗
INSM INSMED INC A Award deriv2013-01-112013-01-158,955— $013,282SEC↗
DUSA DUSA PHARMACEUTICALS INC D To issuer deriv2012-12-202012-12-2015,000— $00SEC↗
DUSA DUSA PHARMACEUTICALS INC U Tender2012-12-202012-12-2010,000$8.00 $80.0K0SEC↗
DUSA DUSA PHARMACEUTICALS INC U Tender2012-12-202012-12-2010,000$8.00 $80.0K0SEC↗
DUSA DUSA PHARMACEUTICALS INC A Award2012-06-302012-07-028,000— $020,000SEC↗